The global fosfomycin calcium market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing prevalence of antibiotic-resistant bacteria and rising demand for antimicrobial agents in emerging economies such as China and India. The global fosfomycin calcium market is segmented on the basis of type, application, and region. On the basis of type, it is segmented into tablets and injection. On the basis of application, it is segmented into medical and microbiology. On the basis of region, it is segmented into North America (US, Canada), Latin America (Brazil), Europe (Germany), Asia Pacific (China) and Middle East & Africa (Saudi Arabia).
Some Of The Growth Factors Of This Market:
- Fosfomycin is a broad-spectrum antibiotic that is used to treat urinary tract infections, intra-abdominal infections, and other bacterial infections.
- Fosfomycin has been shown to be effective against drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA).
- The use of fosfomycin in the treatment of MRSA has been increasing in recent years due to the emergence of drug resistance among other antibiotics.
- Fosfomycin is not absorbed from the gastrointestinal tract and must be given intravenously or intramuscularly for systemic use; this limits its usefulness for oral therapy but makes it an attractive option for patients with severe diarrhea or vomiting who are unable to take oral medication because they are unable to keep it down long enough for it to work effectively.
- The FDA approved fosfomycin on December 18, 2016 as an alternative treatment option for uncomplicated UTIs when certain antibiotics cannot be taken or have failed.
Industry Growth Insights published a new data on “Fosfomycin Calcium Market”. The research report is titled “Fosfomycin Calcium Market research by Types (Tablets, Injection), By Applications (Medical, Microbiology, Others), By Players/Companies Northeast Pharm, Ercros, Shinpoong Pharm, Manus Aktteva Biopharma LLP, FarmaSino Pharmaceutical, Merck KGaA, Hubei Xunda Pharmaceutical, Guangxi Nanning Baihui Pharmaceutical, Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd., Shanxi Dongjin Pharmaceutical Co., Ltd., Shanghai Wuzhou Pharmaceutical, Shanghai Xinya Pharmaceutical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Fosfomycin Calcium Market Research Report
By Type
Tablets, Injection
By Application
Medical, Microbiology, Others
By Companies
Northeast Pharm, Ercros, Shinpoong Pharm, Manus Aktteva Biopharma LLP, FarmaSino Pharmaceutical, Merck KGaA, Hubei Xunda Pharmaceutical, Guangxi Nanning Baihui Pharmaceutical, Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd., Shanxi Dongjin Pharmaceutical Co., Ltd., Shanghai Wuzhou Pharmaceutical, Shanghai Xinya Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Fosfomycin Calcium Market Report Segments:
The global Fosfomycin Calcium market is segmented on the basis of:
Types
Tablets, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical, Microbiology, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Northeast Pharm
- Ercros
- Shinpoong Pharm
- Manus Aktteva Biopharma LLP
- FarmaSino Pharmaceutical
- Merck KGaA
- Hubei Xunda Pharmaceutical
- Guangxi Nanning Baihui Pharmaceutical
- Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.
- Shanxi Dongjin Pharmaceutical Co., Ltd.
- Shanghai Wuzhou Pharmaceutical
- Shanghai Xinya Pharmaceutical
Highlights of The Fosfomycin Calcium Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablets
- Injection
- By Application:
- Medical
- Microbiology
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fosfomycin Calcium Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fosfomycin calcium is a type of antibiotic that is used to treat infections caused by bacteria. It works by killing the bacteria cells.
Some of the major companies in the fosfomycin calcium market are Northeast Pharm, Ercros, Shinpoong Pharm, Manus Aktteva Biopharma LLP, FarmaSino Pharmaceutical, Merck KGaA, Hubei Xunda Pharmaceutical, Guangxi Nanning Baihui Pharmaceutical, Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd., Shanxi Dongjin Pharmaceutical Co., Ltd., Shanghai Wuzhou Pharmaceutical, Shanghai Xinya Pharmaceutical.
The fosfomycin calcium market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Fosfomycin Calcium Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Fosfomycin Calcium Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Fosfomycin Calcium Market - Supply Chain
4.5. Global Fosfomycin Calcium Market Forecast
4.5.1. Fosfomycin Calcium Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Fosfomycin Calcium Market Size (000 Units) and Y-o-Y Growth
4.5.3. Fosfomycin Calcium Market Absolute $ Opportunity
5. Global Fosfomycin Calcium Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Fosfomycin Calcium Market Size and Volume Forecast by Type
5.3.1. Tablets
5.3.2. Injection
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Fosfomycin Calcium Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Fosfomycin Calcium Market Size and Volume Forecast by Application
6.3.1. Medical
6.3.2. Microbiology
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Fosfomycin Calcium Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Fosfomycin Calcium Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Fosfomycin Calcium Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Fosfomycin Calcium Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Fosfomycin Calcium Demand Share Forecast, 2019-2026
9. North America Fosfomycin Calcium Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Fosfomycin Calcium Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Fosfomycin Calcium Market Size and Volume Forecast by Application
9.4.1. Medical
9.4.2. Microbiology
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Fosfomycin Calcium Market Size and Volume Forecast by Type
9.7.1. Tablets
9.7.2. Injection
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Fosfomycin Calcium Demand Share Forecast, 2019-2026
10. Latin America Fosfomycin Calcium Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Fosfomycin Calcium Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Fosfomycin Calcium Market Size and Volume Forecast by Application
10.4.1. Medical
10.4.2. Microbiology
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Fosfomycin Calcium Market Size and Volume Forecast by Type
10.7.1. Tablets
10.7.2. Injection
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Fosfomycin Calcium Demand Share Forecast, 2019-2026
11. Europe Fosfomycin Calcium Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Fosfomycin Calcium Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Fosfomycin Calcium Market Size and Volume Forecast by Application
11.4.1. Medical
11.4.2. Microbiology
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Fosfomycin Calcium Market Size and Volume Forecast by Type
11.7.1. Tablets
11.7.2. Injection
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Fosfomycin Calcium Demand Share, 2019-2026
12. Asia Pacific Fosfomycin Calcium Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Fosfomycin Calcium Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Fosfomycin Calcium Market Size and Volume Forecast by Application
12.4.1. Medical
12.4.2. Microbiology
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Fosfomycin Calcium Market Size and Volume Forecast by Type
12.7.1. Tablets
12.7.2. Injection
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Fosfomycin Calcium Demand Share, 2019-2026
13. Middle East & Africa Fosfomycin Calcium Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Fosfomycin Calcium Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Fosfomycin Calcium Market Size and Volume Forecast by Application
13.4.1. Medical
13.4.2. Microbiology
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Fosfomycin Calcium Market Size and Volume Forecast by Type
13.7.1. Tablets
13.7.2. Injection
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Fosfomycin Calcium Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Fosfomycin Calcium Market: Market Share Analysis
14.2. Fosfomycin Calcium Distributors and Customers
14.3. Fosfomycin Calcium Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Northeast Pharm
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Ercros
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Shinpoong Pharm
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Manus Aktteva Biopharma LLP
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. FarmaSino Pharmaceutical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Merck KGaA
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Hubei Xunda Pharmaceutical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Guangxi Nanning Baihui Pharmaceutical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Shanxi Dongjin Pharmaceutical Co., Ltd.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Shanghai Wuzhou Pharmaceutical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Shanghai Xinya Pharmaceutical
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook